Oramed Pharmaceuticals (ORMP) Stock Chart & Stock Price History → The ONE AI Stock to own now. (It’s not Nvidia.) (From Weiss Ratings) (Ad) Free ORMP Stock Alerts $2.18 -0.06 (-2.68%) (As of 05/31/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Oramed Pharmaceuticals Stock Price Performance5 Day Performance-6.84%1 Month Performance-6.03%3 Month Performance-33.74%6 Month Performance-1.80%Year-To-Date Performance-5.63%1 Year Performance-46.04% Receive ORMP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Oramed Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Porter & CompanyThe only AI company to buyThe AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. ORMP Stock Chart for Saturday, June, 1, 2024 ORMP Chart by TradingView Oramed Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/31/2024$2.24$2.18-2.68%$2.33$2.18157,751 shs$88.57 million05/30/2024$2.18$2.24+2.75%$2.28$2.1999,473 shs$91.01 million05/29/2024$2.20$2.18-0.91%$2.23$2.15122,267 shs$88.57 million05/28/2024$2.34$2.20-5.98%$2.33$2.20204,073 shs$89.39 million05/27/2024$2.34$2.34$2.36$2.2962,400 shs$95.07 million05/24/2024$2.32$2.34+0.86%$2.36$2.2962,461 shs$95.07 million Get the Latest News and Ratings for ORMP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Oramed Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 05/23/2024$2.30$2.32+0.87%$2.34$2.2391,048 shs$94.26 million05/22/2024$2.31$2.30-0.43%$2.38$2.28138,999 shs$93.45 million05/21/2024$2.37$2.31-2.53%$2.40$2.3191,454 shs$93.86 million05/20/2024$2.30$2.37+3.04%$2.41$2.27112,953 shs$96.29 million05/17/2024$2.33$2.30-1.29%$2.39$2.3043,909 shs$93.45 million05/16/2024$2.39$2.33-2.51%$2.37$2.2699,176 shs$94.67 million05/15/2024$2.47$2.39-3.24%$2.44$2.36123,034 shs$97.11 million05/14/2024$2.41$2.47+2.49%$2.49$2.4270,479 shs$100.35 million05/13/2024$2.40$2.41+0.63%$2.46$2.3962,551 shs$97.92 million05/10/2024$2.38$2.40+0.63%$2.45$2.3576,371 shs$97.04 million05/09/2024$2.43$2.38-2.06%$2.44$2.3246,422 shs$96.44 million05/08/2024$2.40$2.43+1.25%$2.45$2.3950,298 shs$98.46 million05/07/2024$2.49$2.40-3.61%$2.49$2.3959,978 shs$97.25 million05/06/2024$2.35$2.49+5.96%$2.55$2.37109,125 shs$100.90 million05/03/2024$2.34$2.35+0.43%$2.45$2.3564,695 shs$95.22 million05/02/2024$2.34$2.34$2.38$2.24109,244 shs$94.82 million05/01/2024$2.32$2.34+0.86%$2.42$2.2544,022 shs$94.82 million04/30/2024$2.44$2.32-4.72%$2.40$2.3056,860 shs$94.01 million04/29/2024$2.46$2.44-1.02%$2.48$2.3675,910 shs$98.66 million04/26/2024$2.30$2.46+6.96%$2.48$2.3184,471 shs$99.68 million04/25/2024$2.37$2.30-2.95%$2.37$2.20107,258 shs$93.20 million04/24/2024$2.35$2.37+0.85%$2.39$2.3140,834 shs$96.03 million04/23/2024$2.33$2.35+0.86%$2.43$2.3431,031 shs$95.22 million04/22/2024$2.27$2.33+2.64%$2.39$2.2559,020 shs$94.41 million04/19/2024$2.20$2.27+3.18%$2.30$2.18113,647 shs$91.98 million04/18/2024$2.33$2.20-5.58%$2.37$2.14240,759 shs$89.14 million04/17/2024$2.40$2.33-2.92%$2.41$2.27149,862 shs$94.41 million04/16/2024$2.42$2.40-0.83%$2.45$2.33116,858 shs$97.25 million04/15/2024$2.52$2.42-3.97%$2.57$2.40152,599 shs$98.06 million04/12/2024$2.58$2.52-2.33%$2.64$2.5072,512 shs$102.11 million04/11/2024$2.66$2.58-3.01%$2.69$2.57108,919 shs$104.54 million04/10/2024$2.69$2.66-1.12%$2.73$2.6463,588 shs$107.78 million04/09/2024$2.77$2.69-2.89%$2.81$2.66116,299 shs$109.00 million04/08/2024$2.61$2.77+6.13%$2.80$2.6484,270 shs$112.24 millionThe #1 Crypto That You Don’t Own… Yet (Ad)There’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay attention to above all others: Venture capital firms. You want to follow venture capital money into cryptocurrencies before anyone gets word of what’s happening.Click here for all the details…04/05/2024$2.61$2.61$2.69$2.51171,934 shs$105.76 million04/04/2024$2.75$2.61-5.09%$2.80$2.61177,559 shs$105.76 million04/03/2024$2.80$2.75-1.79%$2.80$2.7297,919 shs$111.43 million04/02/2024$2.83$2.80-1.06%$2.83$2.7381,209 shs$113.46 million04/01/2024$2.92$2.83-3.08%$2.95$2.78112,863 shs$114.67 million03/29/2024$2.92$2.92$3.14$2.78211,195 shs$118.32 million03/28/2024$2.82$2.92+3.55%$3.14$2.79209,506 shs$118.32 million03/27/2024$2.72$2.82+3.68%$2.84$2.66160,213 shs$114.27 million03/26/2024$2.76$2.72-1.45%$2.83$2.6988,737 shs$110.21 million03/25/2024$2.91$2.76-5.15%$2.89$2.71167,534 shs$111.84 million03/22/2024$2.80$2.91+3.93%$2.93$2.7868,844 shs$117.91 million03/21/2024$2.96$2.80-5.41%$3.03$2.79141,277 shs$113.45 million03/20/2024$2.83$2.96+4.59%$2.99$2.82136,261 shs$119.94 million03/19/2024$2.81$2.83+0.71%$2.91$2.7880,742 shs$114.67 million03/18/2024$2.92$2.81-3.77%$2.96$2.7992,944 shs$113.86 million03/15/2024$2.68$2.92+8.96%$2.92$2.6979,678 shs$118.32 million03/14/2024$2.77$2.68-3.25%$2.80$2.6597,837 shs$108.59 million03/13/2024$2.86$2.77-3.15%$2.89$2.74124,349 shs$112.24 million03/12/2024$2.94$2.86-2.72%$2.94$2.77169,155 shs$115.89 million03/11/2024$2.98$2.94-1.34%$3.07$2.9199,897 shs$119.13 million03/08/2024$2.86$2.98+4.20%$3.01$2.8696,261 shs$120.21 million03/07/2024$2.87$2.86-0.35%$3.01$2.80148,116 shs$115.37 million03/06/2024$3.26$2.87-11.96%$3.20$2.75490,308 shs$115.78 million03/05/2024$3.25$3.26+0.31%$3.29$3.19109,021 shs$131.51 million03/04/2024$3.42$3.25-4.97%$3.37$3.21125,170 shs$131.11 million03/01/2024$3.29$3.42+3.95%$3.45$3.29109,061 shs$137.96 million02/29/2024$3.41$3.29-3.52%$3.48$3.21200,189 shs$132.72 million Related Companies: FibroBiologics Stock Chart Verrica Pharmaceuticals Stock Chart Shattuck Labs Stock Chart AC Immune Stock Chart Organogenesis Stock Chart Amarin Stock Chart Alto Neuroscience Stock Chart Precigen Stock Chart Skye Bioscience Stock Chart Silverback Therapeutics Stock Chart Receive ORMP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Oramed Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ORMP) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaBiden Nomination CANCELED?The Freeport SocietyOn June 10, Nvidia makes its next big moveWeiss RatingsMAJOR BUY SIGNAL: Move Fast, Washington/Pelosi/Mill…AltimetryUnlock Explosive Gains with This Defense StockBehind the MarketsMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin Pro Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oramed Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.